Jin Sheng
Sir Run Run Shaw Hospital
Hangzhou, China
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Clinicopathological characteristics and treatment patterns of combined small-cell lung cancer: a real-world single-center study with a mini review.
Journal: Frontiers in immunology
Published: June 24, 2025
SMARCA4-deficient NSCLC treated with first-line tislelizumab and fruquintinib achieved remarkable tumor regression: case report and literature review.
Journal: Frontiers in immunology
Published: November 03, 2024
De Novo MET-amplified NSCLC treated with savolitinib achieved remarkable tumor regression: a case report and review of literature.
Journal: Journal of cancer research and clinical oncology
Published: September 30, 2024
Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report.
Journal: Frontiers of medicine
Published: July 27, 2024
BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors.
Journal: NPJ precision oncology
Published: April 04, 2024
Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 19, 2024
Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer.
Journal: Cancers
Published: July 05, 2023
Impact of prophylactic dexamethasone on the efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy in patients with advanced Non-Squamous Non-Small-Cell lung cancer.
Journal: International immunopharmacology
Published: May 14, 2023
Last Updated: 09/26/2026